Similarly low procedure rates have been observed in other Asian populations. 10 The reason for the difference in rates between ethnic groups is unknown, but height may be a factor.
The objectives of this study were to determine the prevalence of lower-extremity amputation among patients with diabetes mellitus (type 1 and type 2) and to evaluate the association between height and lower-extremity amputation, with adjustment for the potential confounding effects of age, sex, duration of diabetes, smoking status, hypertension, fasting plasma glucose level and dyslipidemia.
Methods
A full description of the methods is available in the unabridged version of this article (www.cmaj.ca/cgi/content /full/174/3/319).
In brief, the databases of 66 hospitals and clinics in every region of Taiwan were used to identify all patients seen in these institutions between 1995 and 1998 with a diagnosis of diabetes mellitus. (These databases were used because most diabetic patients in Taiwan receive medical care at such facilities.) The sample is described in detail elsewhere.
Prevalence of lower-extremity amputation among patients with diabetes mellitus: Is height a factor? Background: Taller diabetic patients are at higher risk of peripheral sensory loss than shorter diabetic patients and thus may be at increased risk of lower-extremity ulcers and amputation. In a large telephone survey, the prevalence of lowerextremity amputation among patients with diabetes mellitus was determined and the association between height and lower-extremity amputation evaluated.
Methods:
Of 256 036 patients identified from hospital and clinic databases who had a diagnosis of diabetes and were seen at those institutions between 1995 and 1998, 128 572 were randomly selected to be interviewed by telephone between 1995 and 2002. Of the 93 484 patients who agreed to be interviewed, 386 were excluded (age < 18 years); this left 93 116 diabetec patients (42 970 men and 50 146 women) for inclusion in the study.
Results:
Of the 93 116 patients interviewed, 3259 (3.5%) had type 1 diabetes. Lower-extremity amputation was performed in 1.7% and 0.8% of the patients with type 1 and type 2 diabetes, respectively. The prevalence of amputation did not differ significantly between men and women with type 1 diabetes but was significantly higher among men than among women with type 2 diabetes (0.9% v. 0.7%). Height (every 10-cm increment) was significantly associated with lower-extremity amputation (adjusted odds ratio [OR] 1.16, 95% confidence interval [CI] 1.03-1.32). In a subgroup of 9295 patients for whom data on fasting plasma glucose levels and dyslipidemia were available, and after additional adjustment for these 2 variables, body height remained an independent predictor of lower-extremity amputation (adjusted OR for every 10 cm of height 1.79, 95% CI 1.14-2.82).
Interpretation:
Height is an independent predictor of lowerextremity amputation among patients with type 1 and type 2 diabetes mellitus. extremity amputation; initial symptoms or clinical events that led to the diagnosis of diabetes; current treatment of diabetes; history of smoking; hypertension; and family history of diabetes and hypertension. A subset of the participants who reported having visited a physician in the month before the interview were asked whether they had dyslipidemia and, if so, whether they had received treatment for it; they were also asked for the results of any fasting plasma glucose level obtained in the 3 months before the interview.
Height was categorized into quartiles. Actual and adjusted prevalences of lower-extremity amputations were calculated for each quartile. Logistic regression analyses were used to estimate the odds ratios and 95% confidence intervals for lower-extremity amputation for the various risk factors. Two models were created: the first was for all of the study subjects and adjusted for age, sex, type of diabetes, duration of diabetes, smoking status, hypertension and height. The second model was for the subgroup of patients who reported their fasting plasma glucose level and dyslipidemia status; these 2 factors were entered into the model in addition to the variables used in the first model.
The study design was approved and supported by an ad hoc ethics committee of the Department of Health of Taiwan.
Results
Of the 128 572 randomly selected subjects, 93 484 (72.7%) completed the telephone survey. The age and sex distribution of the respondents was comparable to that of the original cohort of 256 036 diabetic patients.
11,12 A total of 368 patients were excluded because they were less than 18 years old, which left 93 116 respondents; 9295 of them reported their fasting plasma glucose level and dyslipidemia status and were included in the subgroup analysis. Table 1 shows the baseline characteristics of the respondents. A total of 784 patients (0.8%) reported a history of lower-extremity amputation. The age-and sex-specific prevalences of such amputation by type of diabetes are shown in Table 2 . The prevalence increased significantly with age among men and women with type 2 diabetes, but a significant increase with age was evident only among women with type 1 diabetes. Among patients with type 2 diabetes, men were significantly more likely than women to have had a lower-extremity amputation in all age groups except the youngest (< 55 years). Fig. 1 shows the actual and adjusted prevalences of lowerextremity amputation by height quartiles for all of the diabetic patients and for those with type 1 and type 2 diabetes. A significant increase in trends was observed (p < 0.05). Fig. 2 shows the adjusted odds ratios for lower-extremity amputation among all of the subjects (model 1) and among the subgroup of respondents for whom data were available on fasting plasma glucose level and dyslipidemia (model 2). In the first model, all of the factors except for smoking status (current smoker) and sex were found to be significant (Fig. 2,  top panel) . In the subgroup analysis (model 2), height, duration of diabetes, smoking status (ex-smoker), hypertension and fasting plasma glucose level were significant factors (Fig. 2, bottom panel) .
Interpretation
This study revealed a strong and statistically significant association between height and risk of lower-extremity amputation among diabetic patients. The association held even after adjustment for other risk factors for this type of amputation. Every additional 10 cm of height was associated with a 16% increase in the risk of amputation. In the subgroup analysis, in which adjustments were made for additional information on fasting plasma glucose level and dyslipidemia, the adjusted risk of amputation was even larger (79% for every additional 10 cm of height).
This study had several limitations. Sensory dysfunction could not be evaluated. Taller patients are known to be at increased risk of peripheral sensory loss compared with shorter patients. [1] [2] [3] [4] [5] [6] [7] The association between height and lowerextremity amputation would be underestimated if taller patients who had undergone amputation were less healthy and had more comorbidities (e.g., compression of vertebral disc space) than shorter patients who had undergone amputation. The association between height and lower-extremity amputation was stronger in the subgroup analysis that adjusted for fasting plasma glucose level and dyslipidemia than in the main analysis that did not include these 2 factors. Because the data were collected over 7 years, a healthy survivor bias may have existed. If taller patients undergoing lower-extremity amputation are at lower risk of death than shorter patients undergoing such amputation, estimates of the effects of height on amputation might be overestimated. Follow-up of the cohort to determine the incidence of lower-extremity amputation would give a more assured answer.
The association between lower-extremity amputation and weight or body mass index (BMI) was not evaluated in this study because weight and BMI change significantly under different disease conditions and nutritional states and because the weight of lost limbs in amputated patients is difficult to estimate; height, on the other hand, changes minimally and will only decrease after puberty. The significant association between height and lower-extremity amputation persisted even after adjustments for weight and BMI (data not shown).
As in previous studies in Taiwan, 9,11,15 diabetic men were found to be at higher risk of lower-extremity amputation than their female counterparts (Table 2 ). However, in the present study, sex did not remain a significant factor after adjustment for the other confounding variables (Fig. 2) . In fact, in another logistic regression analysis in which only sex and height were included as independent variables, only height Height quartile, cm* Type 1 diabetes was found to be significantly associated with lower-extremity amputation (data not shown). This observation suggests that the difference in amputation prevalence between the men and women was due to a confounding effect of height.
In conclusion, height is a risk factor for lower-extremity amputation among diabetic patients. This effect appears to be independent of other known risk factors. Although the underlying mechanism could not be identified, it may be wise to pay particular attention to the early detection and treatment of leg ulcers in taller patients with diabetes. Fig. 2 : Multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for lower-extremity amputation among all 93 116 diabetic patients (top panel) and among the 9295 patients for whom data of fasting plasma glucose (FPG) levels and history of dyslipidemia were available (bottom panel). *p < 0.01; †p < 0.05. 
